AlphaCrest Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-25,778
Closed -$2.22M 721
2022
Q3
$2.22M Buy
+25,778
New +$2.3M 0.14% 198
2022
Q2
Sell
-16,747
Closed -$1.37M 1318
2022
Q1
$1.37M Sell
16,747
-103,272
-86% -$8.14M 0.08% 400
2021
Q4
$9.2M Buy
120,019
+108,754
+965% +$8.66M 0.34% 33
2021
Q3
$846K Buy
+11,265
New +$857K 0.04% 681
2021
Q2
Sell
-181,877
Closed -$13.4M 1306
2021
Q1
$13.4M Buy
181,877
+147,176
+424% +$10.9M 0.75% 7
2020
Q4
$2.71M Buy
34,701
+10,889
+46% +$833K 0.22% 100
2020
Q3
$1.89M Sell
23,812
-7,265
-23% -$569K 0.2% 103
2020
Q2
$2.29M Buy
31,077
+8,799
+39% +$662K 0.38% 37
2020
Q1
$1.64M Buy
22,278
+14,910
+202% +$1.17M 0.2% 120
2019
Q4
$639K Sell
7,368
-21,849
-75% -$1.79M 0.05% 618
2019
Q3
$2.35M Sell
29,217
-14,483
-33% -$1.16M 0.14% 177
2019
Q2
$3.5M Buy
43,700
+34,351
+367% +$2.63M 0.3% 44
2019
Q1
$742K Buy
9,349
+4,737
+103% +$354K 0.11% 300
2018
Q4
$336K Buy
+4,612
New +$326K 0.1% 401

Other funds holding MRK

AlphaCrest Capital Management's MRK Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of Merck (MRK) in Q4 2022, closing a stake of 25,778 shares — an estimated $2.22M sold.

AlphaCrest Capital Management first reported a position in MRK in Q4 2018 and held it in 14 quarters. The position peaked at $13.4M in Q1 2021. 3,234 funds tracked by Wall St. Rank hold MRK as of Q4 2022.

  • AlphaCrest Capital Management reported no remaining Merck position as of Q4 2022 after selling out during the quarter.
  • AlphaCrest Capital Management sold 25,778 Merck shares in Q4 2022, an estimated $2.22M.
  • AlphaCrest Capital Management first reported a position in Merck in Q4 2018 and held it in 14 quarters.
  • AlphaCrest Capital Management's Merck position peaked at $13.4M in Q1 2021.
  • 3,234 funds tracked by Wall St. Rank held Merck as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.